Carfilzomib‐Induced Thrombotic Microangiopathy—Two Case Reports

ABSTRACTBackgroundThrombotic microangiopathy (TMA) is a pathological syndrome characterized by a combination of three key features: microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and organ damage, primarily affecting the kidneys. There are several drugs known to have a definite or proba...

詳細記述

書誌詳細

出版年:	Cancer Reports
主要な著者:	Irene Attucci, Sofia Pilerci, Maria Messeri, Ludovica Pengue, Giulia Tomasino, Leonardo Caroti, Alessandro M. Vannucchi, Elisabetta Antonioli
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2024-10-01
主題:	carfilzomib proteasome inhibitors renal impairment thrombotic microangiopathy
オンライン･アクセス:	https://doi.org/10.1002/cnr2.2163